Purolite, a subsidiary of Ecolab that produces purification resins for drug manufacturing, earmarked at least $190 million to build a production plant that will employ 170 workers.The facility, which will produce a variety of products for the healthcare and drug manufacturing industries, will be located in Landenberg, Pennsylvania, according to a June 6 press release from Gov. Josh Shapiro’s office.
Resins are used to purify process streams during drug manufacturing and are considered critical to final product quality although they are not part of the finished product.
The facility is expected to be completed by the first half of 2025. It will represent the first site in Purolite's U.S. biologics division.
“Purolite’s new facility will help bring security of supply to our global pharmaceutical and biotech customers, enabling lifesaving drugs to reach patients fast,” Hayley Crowe, Purolite’s senior vice president and general manager, said in the release.
Purolite received a funding proposal from the state’s Department of Community and Economic Development for just over $1 million.

Reference: https://deal.town/questex/060823-pfizer-in-411m-deal-with-samsung-biologics-cancer-group-puts-numbers-behind-chemo-drug-shortage-F3MA2WSU9